We provide complex genomic biomarker support for the UK-wide PrecisionPanc network, as well as supporting the PRIMUS drug trials within the platform.
We work closely with NHS laboratories in the delivery of clinical assays, pathways and analytics, in addition to supporting NHS-wide initiatives as part of the national genomic reconfiguration.
GPOL receives support from industry through investigator-initiated clinical trials and collaborative research with commercial partners.
Our Medical Genomics team was one of 3 UK groups to participate in a collaborative study with the National Institute of Biological Standards and Controls (NIBSC) initiative to establish the first proposed WHO International Standards for Cancer Genomes.
GPOL is also a major supporter of the International Cancer Genome Consortium (ICGC) , and Prof Biankin is currently the Executive Director.
